Woodhouse Edwin Wilbur, Alsoubani Majd, Roach David J, Flynn David B, LaValley Michael, Sheridan Kristen, Hooper David C, Fowler Vance G, Duffy Erin M, Grossman Trudy H
Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina, USA.
Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, Massachusetts, USA.
Open Forum Infect Dis. 2025 Jul 2;12(7):ofaf365. doi: 10.1093/ofid/ofaf365. eCollection 2025 Jul.
Infections following colonization of multidrug-resistant gram-negative bacteria (MDR-GNB), particularly Enterobacterales with extended-spectrum beta-lactamases (ESBL-E) or carbapenem-resistant Enterobacterales (CRE), represent a major global health threat. Our aim was to assess quality of evidence and provide estimates on rate of infection following colonization with multidrug-resistant gram-negative bacteria.
We performed an umbrella review of systematic reviews and meta-analyses. Quality was assessed using the AMSTAR 2 tool, and a meta-analysis was performed to estimate rate of infection.
An initial search for systematic reviews and meta-analyses yielded 847 results, with 17 articles ultimately included. After exclusion of 2 studies for overlapping results and very low quality, the pooled incidence of infection following colonization across the studies was 22% for ESBL-E and 22% for CRE. Few reviews included high-quality findings on mortality or transmission following colonization. Additionally, only a limited number of reviews included findings related to MDR or carbapenem-resistant
Our results suggest a substantial rate of infection following colonization of multidrug-resistant gram-negative bacteria. These findings can inform individual patient counseling, future decolonization innovation, clinical trial design, and regulatory approval of new decolonization agents. However, the heterogeneity of the included populations may limit the generalizability of these findings.
多重耐药革兰氏阴性菌(MDR - GNB)定植后的感染,尤其是产超广谱β-内酰胺酶(ESBL - E)的肠杆菌科细菌或耐碳青霉烯类肠杆菌科细菌(CRE)引起的感染,是全球主要的健康威胁。我们的目的是评估证据质量,并提供多重耐药革兰氏阴性菌定植后感染率的估计值。
我们对系统评价和荟萃分析进行了一项汇总分析。使用AMSTAR 2工具评估质量,并进行荟萃分析以估计感染率。
对系统评价和荟萃分析的初步检索产生了847个结果,最终纳入17篇文章。排除2项结果重叠且质量极低的研究后,各研究中定植后感染的合并发生率在ESBL - E为22%,在CRE为22%。很少有综述包含关于定植后死亡率或传播的高质量研究结果。此外,只有少数综述包含与MDR或耐碳青霉烯类相关的研究结果。
我们的结果表明多重耐药革兰氏阴性菌定植后感染率较高。这些发现可为个体患者咨询、未来去定植创新、临床试验设计以及新去定植药物的监管批准提供参考。然而,纳入人群的异质性可能会限制这些发现的普遍性。